Figure 4

Flow cytometry results of HepG2 cells after treating with bioavailable fractions of Cur or CurDD. (A) Control group. (B) Treated with bioavailable fraction of Cur. (C) Treated with bioavailable fraction of CurDD. Q1 = Live cells, Q2 = Early apoptosis, Q3 = Late apoptosis and Q4 = Necrosis.